Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
MDGL
Stock Latest News
The Fly
Madrigal Pharmaceuticals price target raised to $554 from $390 at TD Cowen
3d ago
MDGL
Premium
Ratings
Madrigal Pharmaceuticals: Pioneering MASH Treatment with Rezdiffra’s European Market Breakthrough
7d ago
MDGL
Premium
The Fly
Madrigal Pharmaceuticals price target raised to $485 from $483 at Citizens JMP
9d ago
MDGL
Premium
The Fly
Madrigal gets conditional marketing authorization for Rezdiffra from EC
9d ago
MDGL
Premium
Ratings
Buy Rating Affirmed for Madrigal Pharmaceuticals Amid Market Expansion Opportunities
10d ago
MDGL
Premium
Market News
Novo Nordisk (NVO) Stock Gains as Wegovy Drug Gets FDA Nod for Liver Disease
11d ago
LLY
NVO
Premium
Ratings
Madrigal Pharmaceuticals: Strong Buy Rating Backed by Rezdiffra’s Market Success and Strategic Expansion
16d ago
MDGL
Premium
The Fly
Madrigal Pharmaceuticals price target raised to $523 from $458 at UBS
17d ago
MDGL
Premium
Company Announcements
Madrigal Pharmaceuticals Reports Strong Growth Amid Challenges
22d ago
MDGL
Premium
Ratings
Madrigal Pharmaceuticals: Strategic Growth and Market Potential Driven by Rezdiffra’s Success and Key Acquisitions
23d ago
MDGL
Premium
Ratings
Cautious Outlook on Madrigal Pharmaceuticals: Sell Rating Amid Competitive Pressures and Valuation Concerns
23d ago
MDGL
Premium
The Fly
Madrigal Pharmaceuticals price target raised to $428 from $420 at Canaccord
23d ago
MDGL
Premium
Company Announcements
Madrigal Pharmaceuticals Reports Strong Q2 2025 Results
23d ago
MDGL
Premium
The Fly
Madrigal Pharmaceuticals reports Q2 EPS ($1.90), consensus ($3.53)
24d ago
MDGL
Premium
Pre-Earnings
MDGL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
26d ago
MDGL
Premium
Company Announcements
Madrigal Pharmaceuticals Signs Global License Agreement
30d ago
8K
MDGL
Premium
The Fly
Madrigal Pharmaceuticals enters license pact with CSPC for SYH2086
30d ago
MDGL
Premium
Ratings
Madrigal Pharmaceuticals: Strengthened Financial Position and Promising Pipeline Expansion Drive Buy Rating
1M ago
MDGL
Premium
Ratings
Madrigal Pharmaceuticals: Strategic Financing and Growth Potential Justify Buy Rating
1M ago
MDGL
Premium
Company Announcements
Madrigal Pharmaceuticals Secures $500M Credit Facility
1M ago
8K
MDGL
Premium
The Fly
Madrigal Pharmaceuticals secures $500M in senior secured credit
1M ago
OWL
MDGL
Premium
The Fly
Madrigal Pharmaceuticals rises 12.4%
1M ago
MDGL
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
